Effer-Soda® is a highly stable mixture of surface modified sodium carbonate and sodium bicarbonate powder developed for use in pharmaceutical and nutraceutical application. Effervescent delivery systems can provide a number of advantages, including possible improved bioavailability and faster on set of therapeutic action.
These convenient dosage forms are fast dissolving, highly soluble, and stable. For example, effervescent tablets provide the ease of carrying a tablet while at the same time giving the bioavailability of ingesting a solution. For these reasons, the delivery form is popular for many pharmaceutical products such as antacids, analgesic, or cough / cold formulations and nutraceutical product such as multi-vitamin and calcium supplement formulations.
Sodium bicarbonate is a primary ingredient in effervescent tablets and powders. Together with an acid, such as citric acid or tartaric acid, sodium bicarbonate reacts in the presence of water to the produce carbon dioxide (CO2). Consequently, the major disadvantage of sodium bicarbonate is that, in the presence of minute amounts of moisture and acid, it immediately effervesces.
This reactivity can lead to formulation instability and premature effervescence on stability and storage. Also, additional steps to pre-dry the powder along with special equipment and processing conditions are required during manufacture in order to avoid premature effervescence.
Effer-Soda® effectively protects against premature effervescence by reducing the moisture sensitivity of the formulation. This is accomplished by modifying the surface of the sodium bicarbonate with a desiccant skin of sodium carbonate that surrounds the sodium bicarbonate core.
This desiccant skin acts to protect the faster reducing sodium bicarbonate core by absorbing small amounts of moisture and thus reducing the possibility of premature effervescence in formulations. However, in the presence of large amounts of water, Effer-Soda®s readily dissolves and provides rapid effervescence.
Facts:
Contact us for application engineering advice!
Pharmasperse® 416 is specifically engineered for the ready manufacture of orally dispersible powder (ODP) formulations intended for filling into sachets or stickpacks. These highly portable dosage forms offer an attractive alternative to tablet formulations, particularly for populations that may have difficulty taking solid oral dose medications (such as geriatric and pediatric patients). Pharmasperse is a versatile drug delivery system comprised of excipients that meet globally accepted compendia. This innovative platform is easy to use and offers a number of formulation advantages including:
Pharmasperse is designed to provide the functional properties required to formulate a high quality orally dispersible powder dosage form:
The rapid speed of suspension of Pharmasperse helps to deliver fast therapeutic relief resulting in better patient outcomes.
Pharmasperse is chemically stable and has low hygroscopicity. The low hygroscopicity helps to protect moisture sensitive active pharmaceutical ingredients (API) and can improve the stability of the formulation.
Description | A white to off-white and free flowing granular powder |
Mean Particle Size d(0,5) | Approx. 350 µm |
Bulk Density | Approx. 0,6 g/ml |
Tapped Density | Approx. 0,7 g/ml |
Flow / Carr`s Index | Approx. 14 |
* Typical properties not intended to be product specifications.
Pharmaburst® 500 is the global standard for orally disintegrating tablets (ODT). Its performance and versatility makes it an ideal choice among formulators to address many different pharmaceutical or nutraceutical product development challenges.
Global pharmaceutical manufacturers chose Pharmaburst technology because of its many benefits :
Pharmaburst is a co-processed platform comprised of excipients that meet globally accepted compendia. It has an optimum blend of polyols that deliver a smooth, creamy texture with a pleasant cooling sensation. It also has a neutral background flavor, allowing Pharmaburst to accommodate any desired flavor profile for customer satisfaction.
Due to the highly compactable nature of Pharmaburst 500, robust tablets can be made by direct compression employing relatively low forces. Manufacturing robust tablets at lower compression forces reduces the stress applied to multiparticulates such as taste masked actives, thereby ensuring that the integrity of the coating is maintained.
When Pharmaburst is compressed, the co-processed granules break to form very small plate-like particles called microplates. These microplates make tablets formulated with Pharmaburst 500 highly porous resulting in rapid disintegration. The tight association between the microplates make Pharmaburst highly compactible and provides high drug loading capacity.
Fast disintegration time of 30 seconds or less is crucial for patient compliance with an orally dispersible tablet. Pharmaburst 500 produces fast disintegrating tablets that are hard enough to withstand the mechanics of production, storage, transportation, and being pushed out of a blister pack, yet it will disintegrate rapidly so the patient can swallow comfortably.
High Dilution Capacity
The compaction behavior of Pharmaburst 500 contributes to its ability to carry high drug loads. This is due to the co-processed granules fracturing around the drug particles during compression and filling in the void spaces.
Orally disintegrating tablets formulated with Pharmaburst are also easy to manufacture using standard direct compression equipment and processes. The active(s) are simply blended with Pharmaburst, flavors, sweeteners and colors. The lubricant is added in the final step and blended for the prescribed amount of time
These necessary cookies provide basic functions of our website. Without these cookies you cannot use e.g. youtube videos or logins. The website will therefore not function properly without these cookies.
Name | Hosts | Description | Expiration | Type |
---|---|---|---|---|
PHPSESSID | www.lehvoss-pharma.de | Stores login data |
When browser is closed | HTTP |
fe_typo_user | TYPO3 | This cookie activates basic functions and is required for the website to function properly. |
When browser is closed | HTTP |
be_typo_user | TYPO3 | This cookie is a standard TYPO3 session cookie. In the case of a backend login, it saves the session ID. |
When browser is closed | HTTP |
Youtube | www.youtube.com | |||
dv_consent | TYPO3 | Saves your cookie and tracking settings. If you delete this cookie, you will have to make the settings again. |
When browser is closed | HTTP |
These cookies help us to see how visitors use our sites. This information is collected anonymously.
Name | Hosts | Description | Expiration | Type |
---|---|---|---|---|
_ga | Google generates usage statistics; data can also be used in Google products, for example to display more relevant advertising and to measure interactions with this advertising. |
2 years | HTTP | |
_gid | Google Anayltics assigns an ID and collects statistical information about how the user uses the site. |
2 years | HTTP | |
_gat | Used by Google Analytics to monitor the request rate - e.g. which areas of the website need improvement. No personal data is collected. |
2 years | HTTP |